ES2059775T3 - Composicion que contiene morfina. - Google Patents

Composicion que contiene morfina.

Info

Publication number
ES2059775T3
ES2059775T3 ES89308659T ES89308659T ES2059775T3 ES 2059775 T3 ES2059775 T3 ES 2059775T3 ES 89308659 T ES89308659 T ES 89308659T ES 89308659 T ES89308659 T ES 89308659T ES 2059775 T3 ES2059775 T3 ES 2059775T3
Authority
ES
Spain
Prior art keywords
composition containing
morphine
containing morphine
inclusion
storage stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308659T
Other languages
English (en)
Inventor
Robin Paul Michell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Rorer Ltd
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of ES2059775T3 publication Critical patent/ES2059775T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

EN UNA FORMULACION EFERVESCENTE CONTENIENDO MORFINA, LA INCLUSION DE LA MORFINA EN EL COMPONENTE BASICO DA SUPERIOR ESTABILIDAD DE ALMACENAMIENTO.
ES89308659T 1988-08-26 1989-08-25 Composicion que contiene morfina. Expired - Lifetime ES2059775T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820327A GB8820327D0 (en) 1988-08-26 1988-08-26 New compositions of matter

Publications (1)

Publication Number Publication Date
ES2059775T3 true ES2059775T3 (es) 1994-11-16

Family

ID=10642786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308659T Expired - Lifetime ES2059775T3 (es) 1988-08-26 1989-08-25 Composicion que contiene morfina.

Country Status (15)

Country Link
US (1) US5387420A (es)
EP (1) EP0361680B1 (es)
JP (1) JP2793280B2 (es)
AT (1) ATE108329T1 (es)
AU (1) AU613517B2 (es)
CA (1) CA1338889C (es)
DE (1) DE68916731T2 (es)
DK (1) DK421189A (es)
ES (1) ES2059775T3 (es)
GB (1) GB8820327D0 (es)
HU (1) HU206265B (es)
IE (1) IE63911B1 (es)
NZ (1) NZ230440A (es)
PT (1) PT91553B (es)
ZA (1) ZA896519B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5607940A (en) * 1994-07-18 1997-03-04 Stephen; Robert L. Morphine formulations for use by electromotive administration
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB2307857B (en) * 1995-12-04 1999-01-27 Euro Celtique Sa An effervescent formulation
US6372755B2 (en) 1997-07-11 2002-04-16 Toray Industries, Inc. Stable medicinal compositions containing 4,5-epoxymorphinan derivatives
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
EP1708686B1 (en) 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
DE602004031771D1 (de) 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20080075768A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophobic opioid abuse deterrent delivery system using opioid antagonists
DE102007011485A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5099127B2 (ja) 2007-04-26 2012-12-12 東レ株式会社 ４，５−エポキシモルヒナン誘導体を含有する安定な固形製剤
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
BRPI0912014A2 (pt) * 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
CN102196811B (zh) 2008-10-24 2014-03-19 东丽株式会社 含有4,5-环氧基吗啡烷衍生物的稳定片剂
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
US9579285B2 (en) * 2010-02-03 2017-02-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of an extruder
BR112013005234A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo um polímero aniônico.
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
DK2838512T3 (en) 2012-04-18 2018-11-19 Gruenenthal Gmbh MANIPULATED AND DOSAGE DUMPED PHARMACEUTICAL DOSAGE FORM
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
AU2016299246B2 (en) * 2015-07-24 2021-10-21 Evonik Operations Gmbh Effervescent formulations of ornithine aspartate
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211485A (en) * 1940-08-13 Effervescent acetyl salicylic acid
US3136692A (en) * 1961-06-30 1964-06-09 Strong Cobb Arner Inc Effervescent composition containing polyvinylpyrrolidone
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
US4332789A (en) * 1975-12-15 1982-06-01 Hoffmann-La Roche Inc. Pharmaceutical unit dosage forms
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
JPS61183219A (ja) * 1985-02-07 1986-08-15 Takeda Chem Ind Ltd 発泡組成物の製造法
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions

Also Published As

Publication number Publication date
IE63911B1 (en) 1995-06-14
EP0361680A2 (en) 1990-04-04
JPH02160719A (ja) 1990-06-20
JP2793280B2 (ja) 1998-09-03
EP0361680B1 (en) 1994-07-13
HUT53521A (en) 1990-11-28
DK421189D0 (da) 1989-08-25
ZA896519B (en) 1990-05-30
US5387420A (en) 1995-02-07
DE68916731T2 (de) 1994-12-15
ATE108329T1 (de) 1994-07-15
IE892749L (en) 1990-02-26
PT91553A (pt) 1990-03-08
CA1338889C (en) 1997-02-04
AU613517B2 (en) 1991-08-01
DK421189A (da) 1990-02-27
DE68916731D1 (de) 1994-08-18
PT91553B (pt) 1995-07-06
HU206265B (en) 1992-10-28
NZ230440A (en) 1990-10-26
EP0361680A3 (en) 1990-04-11
GB8820327D0 (en) 1988-09-28
AU4081089A (en) 1990-03-01

Similar Documents

Publication Publication Date Title
ATE108329T1 (de) Morphin enthaltende zusammensetzung.
MX9205345A (es) Alquil-bisacilfosfinoxidos y composicion que contienen los mismos.
FI893127A0 (fi) Komposition som bildar en vattenavstoetande film.
DE68907659D1 (de) Warmhaertende organosiloxanzusammensetzung.
FR2676173B1 (fr) Composition cosmetique contenant un agent alcalinisant sans odeur.
DE69016371D1 (de) Nitrotriazalon enthaltende gaserzeugende Zusammensetzungen.
FI891395L (fi) Eldbestaendig olefinhartskomposition.
DE68913693D1 (de) Aerosol-Zusammensetzung.
DE68909912D1 (de) Saugfähiger Artikel.
DE68916395D1 (de) Zusammensetzung.
FI892175A7 (fi) Säilytysainekompositiot
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
DE58902016D1 (de) Ablege-einrichtung.
FI892744L (fi) Flocklimkomposition.
DE68918483D1 (de) Wasserquellfähige Harzzusammensetzung.
MX14512A (es) Composicion fotopolimerizable y articulo que comprende la composicion.
DE68906407D1 (de) Poly(cyanoarylether) enthaltende zusammensetzung.
DE68911597D1 (de) Harzzusammensetzung.
DE68909636D1 (de) Adhäsive Zusammensetzung.
DE68903729D1 (de) Tertiaere thiolaethoxylat-zusammensetzung.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
DE68912215D1 (de) Aerosolzusammensetzung.
DE68914386D1 (de) Zahnpastaähnliche Zusammensetzung.
FI892552A0 (fi) Benzoyl- och ketonperoxidkomposition.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 361680

Country of ref document: ES